BOSTON–(BUSINESS WIRE)–Leostream Corporation, creator of the world-leading Leostream® Remote Desktop Access Platform, will show broadcast/entertainment
For decades, motion picture productions in British Columbia faced a recurring logistical nightmare: the “Subway
Pharma Fusion Announces Acquisition of Columbia Pharmacy, Further Strengthening National Specialty Infrastructure and Next-Generation Patient
Collaboration delivers landlord-specific coverage, CoverageCheck verification tools, and a referral revenue stream to 460+ franchise
MIAMI, FL / ACCESS Newswire / April 7, 2026 / HEICO Corporation (NYSE:HEI.A)(NYSE:HEI) today announced
Apply before September 30, 2026, for a chance to win $2,500. MANHATTAN, NY / ACCESS
MONTRÉAL, QC / ACCESS Newswire / April 7, 2026 / First Canadian Graphite Inc. (TSXV:FCI)(OTC:GRAPF)
FRISCO, TX / ACCESS Newswire / April 7, 2026 / GameSquare Holdings, Inc. (NASDAQ:GAME), (“GameSquare”,
First-of-its-kind platform spans soda, water, and supplements, combining patented mineral science and formulations, clean ingredients,
POTOMAC, MD / ACCESS Newswire / April 7, 2026 / IGC Pharma, Inc. (NYSE American:IGC)
~Continued funding underscores investor confidence and supports advancement of abuse- and overdose-resistant analgesics~ SAN DIEGO,
Management Highlights 10x Liquidity Coverage and Significant Valuation Gap SCOTTSDALE, AZ / ACCESS Newswire /
WARWICK, GB / ACCESS Newswire / April 7, 2026 / Moolec Science Limited, a wholly
Discover how Sajid’s passion for energy efficiency and drive to think big led him to
MARION, NC / ACCESS Newswire / April 7, 2026 / Greene Concepts, Inc. (OTCID:INKW), owner
Montreal-based real estate investor reinforces long-term commitment to safe, stable housing for low-income residents MONTRÉAL,
TORONTO, ON / ACCESS Newswire / April 7, 2026 / Revival Gold Inc. (TSXV:RVG)(OTCQX:RVLGF) (“Revival
NEW YORK CITY, NY / ACCESS Newswire / April 7, 2026 / MyFlyYatra, an emerging
Gold and Critical Elements in the Mineral-Rich Province of New Brunswick, Canada MIRAMICHI, NB /
Plans Underway to Expand Use to Pediatrics, Patient Redosing and European Approval Meg Flippin, Benzinga
